Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether or not the use of a nonpharmacologic intervention (single point cane) is effective in the treatment of knee osteoarthritis.
Osteoarthritis (OA), the most common joint disease in humans, is a significant cause of pain and disability. Non-pharmacological treatments for hip OA include education, exercise, appliances (walking sticks or insoles), and weight reduction if obese or overweight. Canes are often recommended to reduce adverse forces across joints although there is currently no research evidence regarding the efficacy of walking sticks for hip OA. Little information is available regarding the impact of walking aids on psychosocial function and quality of life in individuals with hip OA. This study will evaluate the effects of walking aids in hip OA by examining gait biomechanics, quality of life, pain, and opinions regarding using a cane.
Comparisons: Compare gait biomechanics in people with symptomatic unilateral hip OA while walking with and without a cane at baseline and after 4 weeks of cane use. Compare gait biomechanics in people with symptomatic unilateral hip OA with and without a cane to those of healthy, age-matched controls. Compare pain and health-related quality of life in people with symptomatic unilateral hip OA following 4 weeks of cane use. Determine the association between changes in gait biomechanics, pain, and health-related quality of life in people with symptomatic unilateral hip OA following 4 weeks of cane use.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Adult subjects with hip osteoarthritis | Experimental | Walk with and without a single point cane at baseline and after four weeks |
|
| Healthy Subjects | No Intervention | Healthy adults walking without a cane at baseline |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| single point cane | Device | Adjustable single point cane with SureGrip handle |
|
| Measure | Description | Time Frame |
|---|---|---|
| Gait Velocity | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Gait Velocity With a Cane in Hip OA Subjects | Measured gait velocity when hip OA subjects walked with a cane at the baseline visit. | Baseline |
| Gait Velocity | Gait velocity when adults with symptomatic hip osteoarthritis walked with a cane after four weeks of cane use |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Meika A Fang, MD | VA Greater Los Angeles Healthcare System Department of Medicine; UCLA Department of Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| VA West Los Angeles | Los Angeles | California | 90073 | United States |
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Group 1 | Healthy adults |
| FG001 | Group 2 | Adults with symptomatic hip osteoarthritis |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Group 1 | Healthy adults |
| BG001 | Group 2 | Adults with symptomatic hip osteoarthritis |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Gait Velocity | Analysis was per protocol | Posted | Mean | Standard Deviation | cm/s | Baseline |
|
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Group 1 | Healthy adults |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Meika A. Fang, MD | Arthritis Foundation | 310-478-3711 | 84503 | meika.fang@va.gov |
Not provided
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 4 weeks |
| BG002 |
| Total |
Total of all reporting groups |
| Participants |
|
| Age Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
|
| Secondary | Gait Velocity With a Cane in Hip OA Subjects | Measured gait velocity when hip OA subjects walked with a cane at the baseline visit. | Analysis was per protocol | Posted | Mean | Standard Deviation | cm/s | Baseline |
|
|
|
| Secondary | Gait Velocity | Gait velocity when adults with symptomatic hip osteoarthritis walked with a cane after four weeks of cane use | Analysis was per protocol | Posted | Mean | Standard Deviation | cm/s | 4 weeks |
|
|
|
| 0 |
| 13 |
| 0 |
| 0 |
| EG001 | Group 2 | Adults with symptomatic hip osteoarthritis | 0 | 13 | 0 | 0 |
Not provided
Not provided